Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FGPXE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $80,959
Award facts
- Contract value 100% obligated
- $80,959.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $80,959.16 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a GLP-1 receptor agonist medication used to treat type 2 diabetes. This firm fixed-price, non-competitive delivery order was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical supply vehicle that extends through December 2026 and serves as the primary mechanism for delivering a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages this prime IDC to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities with specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The company's extensive portfolio of competitively awarded federal contracts demonstrates its established capability to meet military and veteran healthcare supply requirements. The DLA is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, indicating potential opportunities for continued engagement with qualified contractors in this strategic healthcare supply segment.
Quick answers
Who was awarded contract SPE2DB25FGPXE?
SPE2DB25FGPXE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FGPXE worth?
The government has obligated $80,959 on SPE2DB25FGPXE.
Is contract SPE2DB25FGPXE an order under another contract?
Yes. SPE2DB25FGPXE is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPXE competed?
The extent of competition for SPE2DB25FGPXE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award